Generation Bio Co. (GBIO)

Import this data to Google Sheets with:

=jivedata("GBIO","financials")

Full statements spill as a table. For one cell: =jivedata("GBIO","Revenue") or =jivedata("GBIO","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

Generation Bio Co.

GBIO • CIK 0001733294

(in thousands, except per share data)	FY 2022	FY 2023	FY 2024	TTM
Revenue from Contract with Customer, Excluding Assessed Tax	—	$5,904	$19,892	$15,270
Operating Income (Loss)	$-141,182	$-138,563	$-142,390	$-69,793
Net Income (Loss) Attributable to Parent	$-136,639	$-126,612	$-131,668	$-62,627
Weighted Average Number of Shares Outstanding, Basic	58,114,893	64,483,520	66,624,249	6,769,149
Comprehensive Income (Loss), Net of Tax, Attributable to Parent	$-136,722	$-126,255	$-131,783	$-62,938
Research and Development Expense	$96,718	$93,617	$61,305	$67,980
General and Administrative Expense	$44,464	$50,850	$37,780	$37,320
Gain (Loss) on Termination of Lease	—	—	$-63,197	$20,237
Operating Expenses	$141,182	$144,467	$162,282	$85,063
Nonoperating Income (Expense)	$4,543	$11,951	$10,722	$10,722
OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax	$-83	$357	$-115	$-311

(in thousands, except per share data)	FY 2022	FY 2023	FY 2024	TTM
Cash and Cash Equivalents, at Carrying Value	$93,171	$66,446	$76,301	$21,940
Marketable Securities, Current	$185,920	$197,918	$108,922	$67,682
Property, Plant and Equipment, Net	$22,215	$25,799	$15,293	$8,853
Accounts Receivable, after Allowance for Credit Loss, Current	—	—	$1,224	$391
Operating Lease, Right-of-Use Asset	$59,208	$69,852	$20,310	$17,429
Nontrade Receivables, Current	—	—	$3,960	$0
Restricted Cash, Noncurrent	$5,692	$5,791	$2,152	$2,152
Prepaid Expense and Other Assets, Current	$7,530	$4,294	$6,456	$2,379
Other Assets, Noncurrent	$1,699	$265	$539	$0
Assets, Current	$287,016	$272,618	$192,903	$93,462
Assets	$376,264	$374,758	$231,197	$121,896
Deferred Revenue, Noncurrent	—	$41,942	$29,161	$30,552
Operating Lease, Liability, Noncurrent	$74,621	$89,774	$80,554	$19,744
Other Liabilities, Noncurrent	—	—	$223	$0
Liabilities	$93,771	$171,630	$144,993	$71,336
Preferred Stock, Value, Issued	$0	$0	—	$0
Common Stock, Value, Issued	$6	$7	$7	$1
Additional Paid in Capital	$727,335	$774,224	$789,083	$794,841
Accumulated Other Comprehensive Income (Loss), Net of Tax	$-83	$274	$159	$8
Retained Earnings (Accumulated Deficit)	$-444,765	$-571,377	$-703,045	$-744,290
Stockholders' Equity Attributable to Parent	$282,493	$203,128	$86,204	$50,560
Accounts Payable, Current	$662	$2,346	$1,408	$2,064
Accrued Liabilities and Other Liabilities	$11,402	$16,529	$10,059	$12,475
Deferred Revenue, Current	—	$12,919	$10,582	$149
Operating Lease, Liability, Current	$7,086	$8,120	$13,006	$6,352
Liabilities, Current	$19,150	$39,914	$35,055	$21,040
Preferred Stock, Shares Authorized	5,000,000	5,000,000	5,000,000	5,000,000
Preferred Stock, Shares Issued	0	0	0	0
Common Stock, Shares Authorized	150,000,000	150,000,000	150,000,000	150,000,000
Common Stock, Shares, Issued	59,505,437	66,205,550	66,971,977	6,735,676

(in thousands, except per share data)	FY 2022	FY 2023	FY 2024	TTM
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect	$-281,974	$-26,626	$6,216	$283
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$98,863	$72,237	$78,453	$91,634
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$-136,639	$-126,612	$-131,668	$-62,627
Share-based Payment Arrangement, Noncash Expense	$24,452	$24,341	$14,609	$8,841
Depreciation, Depletion and Amortization	$5,130	$5,263	$4,931	$4,850
Investment Income, Net, Amortization of Discount and Premium	$2,289	$9,340	$7,853	$4,118
Other Operating Activities, Cash Flow Statement	—	—	$-97	$-359
Asset Impairment Charges	$5,811	$39	$259	$259
Net Cash Provided by (Used in) Operating Activities	$-102,448	$-52,745	$-88,563	$-113,652
Payments to Acquire Property, Plant, and Equipment	$8,801	$7,397	$2,401	$1,083
Proceeds from Sale of Property, Plant, and Equipment	$0	$0	$196	$522
Payments to Acquire Marketable Securities	$323,714	$405,301	$135,266	$85,719
Proceeds from Sale and Maturity of Marketable Securities	$140,000	$403,000	$232,000	$200,000
Net Cash Provided by (Used in) Investing Activities	$-192,515	$-9,698	$94,529	$113,720
Payments of Stock Issuance Costs	$50	$164	$164	$-15
Proceeds from Issuance of Common Stock	$12,360	—	—	$48,360
Proceeds from Stock Options Exercised	$1,260	$546	$436	$436
Payment, Tax Withholding, Share-based Payment Arrangement	$581	$565	$186	$24
Net Cash Provided by (Used in) Financing Activities	$12,989	$35,817	$250	$215
Capital Expenditures Incurred but Not yet Paid	$24	$1,461	$178	$131
Marketable Securities, Unrealized Gain (Loss)	$-83	$356	$-115	$-311
Increase (Decrease) in Accounts Receivable, Related Parties	—	—	$1,224	$-1,821
Increase (Decrease) in Prepaid Expense and Other Assets	$3,489	$-3,156	$1,565	$-1,655
Increase (Decrease) in Other Noncurrent Assets	$1,295	$-1,433	$273	$-3,106
Increase (Decrease) in Accounts Payable	$-1,386	$1,087	$-386	$418
Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities	$795	$4,287	$-7,958	$4,769
Increase (Decrease) in Deferred Revenue	—	$41,596	$-15,118	$-12,006
IncreaseDecreaseInOperatingLeaseLiability	$881	$16,187	$-8,615	$-45,681

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("GBIO","financials")

Full statements spill as a table. For one cell: =jivedata("GBIO","Revenue") or =jivedata("GBIO","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.